Quotient Clinical
28
0
0
25
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
10.7%
3 terminated/withdrawn out of 28 trials
89.3%
+2.8% vs industry average
0%
0 trials in Phase 3/4
20%
5 of 25 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (28)
Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products
Role: collaborator
Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products
Role: collaborator
Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants
Role: collaborator
A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects
Role: collaborator
Bioavailability of Belumosudil (KD025) in Healthy Male Subjects
Role: collaborator
A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses
Role: collaborator
Single Dose Study of ALZ-801 Prototype Tablets
Role: collaborator
Multiple Ascending Dose Study of ALZ-801
Role: collaborator
Radiolabelled IV and Oral Metabolism Study of F901318
Role: collaborator
Impact of Changing the Dosing Regimen on the PK Profile of ODM-203
Role: collaborator
Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol
Role: collaborator
A Phase 1 Study of HBI-3000
Role: collaborator
A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781
Role: collaborator
First-in-Human Single and Multiple Dose of EB8018
Role: collaborator
First in Human Single Ascending Dose Study of MOR107
Role: collaborator
Pharmacokinetics of IV Formulation
Role: collaborator
Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143
Role: collaborator
Phase 1 Absorption Distribution Metabolism and Excretion of AQX-1125
Role: collaborator
Evaluation of Immediate Release Tablet
Role: collaborator
Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation
Role: collaborator